Anthony Cerami

Anthony Cerami
Born October 3, 1940
Newark, New Jersey
Nationality American
Education Rockefeller University, Rutgers University[1]
Occupation Scientist
Employer Warren Pharmaceuticals
Known for Medical Research
Website

Anthony Cerami is an American entrepreneur and award-winning research scientist.

Biography

Anthony Cerami is a member of the National Academy of Sciences (USA) and the Institute of Medicine. He is the founder and Chairman of the Board of Warren Pharmaceuticals, and the founder and chairman of the Board and CEO of Araim Pharmaceuticals.[2] He received a Ph.D. in 1967 from Rockefeller University, New York, completed postdoctoral fellowships at Harvard Medical School, Massachusetts, and at the Jackson Laboratory, Maine, and served for 20 years as Professor and Head of the Laboratory of Medical Biochemistry, and Dean of Graduate and Postgraduate Studies at Rockefeller.[3] In 1991, Dr. Cerami left Rockefeller University to found (with Jeffry Picower) the Picower Institute for Medical Research,[4] which was later acquired by the Feinstein Institute for Medical Research. In 1996, Dr. Cerami and his daughter Carla Cerami established the Kenneth S. Warren Institute, a not-for-profit biomedical research organization.

Research

Anthony Cerami has led research programs into genetic, metabolic and infectious diseases, with the goal of translating scientific discovery into clinically important products. Among the successes of his approach are: glycated hemoglobin to monitor diabetic control,[5] anti-tumour necrosis factor-alpha therapies to treat inflammatory diseases such as Crohn's disease and rheumatoid arthritis,[6][7][8] and, recently, tissue protective cytokines to safely treat devastating diseases and injuries.[9][10][11] He is the recipient the Luft Award in Diabetes[12] and the Frederick Banting Medal for Scientific Achievement, awarded by the American Diabetes Association in recognition of his lifelong work on diabetes.

References

  1. ↑ "CV". Archived from the original on 24 June 2011. Retrieved July 12, 2011.
  2. ↑ "Anthony Cerami, PhD". Archived from the original on 24 June 2011. Retrieved July 13, 2011.
  3. ↑ Cerami, Anthony. "Corporate Profile". Retrieved 2008-07-25.
  4. ↑ Stevens, William K. (1991-08-01). "New York Times article: Noted scientist and staff leave Rockefeller U". The New York Times (The New York Times). Retrieved 2008-07-30.
  5. ↑ Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976). "Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus". N. Engl. J. Med. 295 (8): 417–20. doi:10.1056/NEJM197608192950804. PMID 934240.
  6. ↑ "Hb1Ac". Retrieved July 13, 2011.
  7. ↑ Beutler B, Milsark IW, Cerami A (1985). "Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.". Science 229 (4716): 869–71. doi:10.1126/science.3895437. PMID 3895437.
  8. ↑ Ghezzi P, Cerami A. (2005). "Tumor necrosis factor as a pharmacological target". Mol Biotechnol. 31 (3): 239–44–20. doi:10.1385/MB:31:3:239. PMID 16230774.
  9. ↑ Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M. (2004). "Derivatives of erythropoietin that are tissue protective but not erythropoietic". Science 305 (5681): 184–5. doi:10.1126/science.1098313. PMID 15247477.
  10. ↑ Brines M, Cerami A. (2004). "A boost for translational neuroscience". Science 305 (5681): 184–5. doi:10.1126/science.1100891. PMID 15247460.
  11. ↑ Brines M, Cerami A (2006). "Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.". Kidney Int. 70 (2): 246–50. doi:10.1038/sj.ki.5001546. PMID 16738535.
  12. ↑ "Profile of Anthony Cerami in Cancer Research" (PDF). Cancer Research (journal). Retrieved 2008-07-30.

External links